Clinical Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patients With Refractory Cirrhotic Ascites
NCT06919523
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Refractory Ascites
Interventions
DRUG:
Dapagliflozin 5mg
DRUG:
Standard care treatment
Sponsor
Mansoura University